Acharya S K, Panda S K, Duphare H, Dasarathy S, Ramesh R, Jameel S, Nijhawan S, Irshad M, Tandon B N
All India Institute of Medical Sciences, Ansari Nagar, New Delhi.
Natl Med J India. 1993 Sep-Oct;6(5):202-6.
In developed countries as well as in Southeast Asia, the hepatitis B and C viruses are the main causes of chronic hepatitis. In India, however, there have been no major investigations on the aetiology of chronic hepatitis. (The hepatitis E virus which is responsible for half the sporadic and most of the epidemic cases of acute viral hepatitis in India does not cause chronic disease.) We, therefore, studied the profile of chronic hepatitis in India.
The clinical presentation, aetiology, serology and histological changes were studied prospectively in 48 patients with chronic hepatitis admitted to the All India Institute of Medical Sciences, New Delhi. Of these, 44 (92%) had chronic active hepatitis, 3 (6.3%) had chronic persistent hepatitis and 1 (2%) had chronic lobular hepatitis.
The hepatitis B virus was the aetiological agent in 24 (50%) of these patients, the hepatitis D virus in association with hepatitis B virus in 10 (21%), the hepatitis C virus in 7 (15%) and the non-A, non-B viruses other than the hepatitis C virus in 6 (13%). One patient (2.0%) had autoimmune chronic active hepatitis. Jaundice at presentation was seen in 33 (69%) patients and more than half had hypoalbuminaemia (< 3 g/dl) with a prolonged prothrombin time. Alanine aminotransferase levels were less than 5 times above normal in over two-thirds of the patients. The highest alanine aminotransferase values were observed in patients with hepatitis D virus infection whereas the lowest were seen in patients with non-A, non-B related chronic active hepatitis. Histological examination revealed bridging necrosis in 40 (91%) patients with chronic active hepatitis indicating a severe form of disease. Replication of the hepatitis B virus was seen in 13 patients with chronic hepatitis, 5 of whom had hepatitis D virus-induced chronic hepatitis. Patients with hepatitis B virus replication had higher alanine aminotransferase values and more severe bridging necrosis than patients who did not have replicating viruses. Higher alanine aminotransferase values, ascites and oesophageal varices were encountered more frequently in patients with hepatitis B and D virus than in those with non-A, non-B related chronic hepatitis.
Chronic hepatitis is not uncommon in India. It presents with evidence of severe disease and, as elsewhere, is most frequently caused by the hepatitis B virus.
在发达国家以及东南亚地区,乙型和丙型肝炎病毒是慢性肝炎的主要病因。然而,在印度,尚未对慢性肝炎的病因进行过重大调查。(在印度,戊型肝炎病毒是散发性急性病毒性肝炎病例的半数病因以及大多数流行性急性病毒性肝炎病例的病因,但不会引发慢性病。)因此,我们对印度慢性肝炎的情况进行了研究。
对新德里全印度医学科学研究所收治的48例慢性肝炎患者的临床表现、病因、血清学及组织学变化进行了前瞻性研究。其中,44例(92%)为慢性活动性肝炎,3例(6.3%)为慢性持续性肝炎,1例(2%)为慢性小叶性肝炎。
这些患者中,24例(50%)的病因是乙型肝炎病毒,10例(21%)是丁型肝炎病毒与乙型肝炎病毒合并感染,7例(15%)是丙型肝炎病毒,6例(13%)是除丙型肝炎病毒外的非甲非乙型病毒。1例患者(2.0%)患有自身免疫性慢性活动性肝炎。33例(69%)患者就诊时出现黄疸,半数以上患者白蛋白降低(<3g/dl)且凝血酶原时间延长。超过三分之二的患者丙氨酸转氨酶水平高于正常上限不到5倍。丁型肝炎病毒感染患者的丙氨酸转氨酶值最高,而非甲非乙型相关慢性活动性肝炎患者的丙氨酸转氨酶值最低。组织学检查显示,40例(91%)慢性活动性肝炎患者出现桥接坏死,表明病情严重。13例慢性肝炎患者出现乙型肝炎病毒复制,其中5例患有丁型肝炎病毒引起的慢性肝炎。乙型肝炎病毒复制患者的丙氨酸转氨酶值更高,桥接坏死更严重,与无病毒复制的患者相比。与非甲非乙型相关慢性肝炎患者相比,乙型和丁型肝炎病毒患者丙氨酸转氨酶值更高、腹水和食管静脉曲张更为常见。
慢性肝炎在印度并不罕见。其表现为病情严重,与其他地方一样,最常见的病因是乙型肝炎病毒。